Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma.
about
Treatment of elderly cancer patients with chemotherapy.Doublet chemotherapy in the elderly patient with ovarian cancer.Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients.Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?Tolerance to chemotherapy in elderly patients with cancer.Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin.Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.Considerations regarding the administration of systemic therapy for elderly patients with ovarian cancer.Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC).Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis.
P2860
Q36276360-BB2B0B39-6474-49EE-A560-05F5831B6E46Q36405668-5DB14C04-9CF7-47F4-883A-2DD38E974C0CQ36446316-EFE2544C-11F3-4F7F-9BA9-F7AFF7FD7320Q36694465-7C8A2885-A5DF-4360-9C5F-2A342E47B158Q36715266-1FC56068-1AAA-4318-A4E6-498B0C547D72Q36979335-F25E9DF2-8264-4188-8B11-E964A9319915Q37328679-C6F05017-8DB4-40AA-B018-2C153A99F2A8Q37644543-8E9FBAAC-69A9-47B9-BCC1-973103AE545DQ45423656-81B4C490-DF66-4123-8175-062A5E38DB7FQ50544321-54980FE8-9294-48E5-A7AD-F7F4BF92FD77Q53045551-8BC4C777-476D-4221-B215-C6B75953A810Q55025094-5306142B-9DBE-4C0E-B04D-3EFF59EC470E
P2860
Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Performance status rather than ...... epithelial ovarian carcinoma.
@ast
Performance status rather than ...... epithelial ovarian carcinoma.
@en
type
label
Performance status rather than ...... epithelial ovarian carcinoma.
@ast
Performance status rather than ...... epithelial ovarian carcinoma.
@en
prefLabel
Performance status rather than ...... epithelial ovarian carcinoma.
@ast
Performance status rather than ...... epithelial ovarian carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Performance status rather than ...... epithelial ovarian carcinoma.
@en
P2093
Bo Gronlund
Claus Høgdall
Heine H Hansen
Svend A Engelholm
P2860
P304
P356
10.1002/CNCR.10385
P407
P577
2002-04-01T00:00:00Z